DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
| Revenue (Most Recent Fiscal Year) | $12.14B |
| Net Income (Most Recent Fiscal Year) | $691.53M |
| PE Ratio (Current Year Earnings Estimate) | 13.66 |
| PE Ratio (Trailing 12 Months) | 15.05 |
| PEG Ratio (Long Term Growth Estimate) | 1.12 |
| Price to Sales Ratio (Trailing 12 Months) | 0.91 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 9.26 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 7.50 |
| Pre-Tax Margin (Trailing 12 Months) | 9.70% |
| Net Margin (Trailing 12 Months) | 5.70% |
| Return on Equity (Trailing 12 Months) | 64.42% |
| Return on Assets (Trailing 12 Months) | 4.63% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.19 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.13 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 6.65 |
| Inventory Turnover (Trailing 12 Months) | 70.84 |
| Book Value per Share (Most Recent Fiscal Quarter) | $13.63 |
| Earnings per Share (Most Recent Fiscal Quarter) | $1.87 |
| Earnings per Share (Most Recent Fiscal Year) | $8.47 |
| Diluted Earnings per Share (Trailing 12 Months) | $7.40 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Common Shares Outstanding | 87.70M |
| Free Float | 86.47M |
| Market Capitalization | $11.06B |
| Average Volume (Last 20 Days) | 0.47M |
| Beta (Past 60 Months) | 1.04 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.40% |
| Percentage Held By Institutions (Latest 13F Reports) | 90.12% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |